Artificial membrane-binding proteins stimulate oxygenation of stem cells during engineering of large cartilage tissue

Nature Communications

Volumn 6, Issue , 2015, Pages

  Armstrong, James P K ^a   Shakur, Rameen ^b,c,d   Horne, Joseph P ^a   Dickinson, Sally C ^a   Armstrong, Craig T ^a   Lau, Katherine ^e   Kadiwala, Juned ^b,c   Lowe, Robert ^f   Seddon, Annela ^a   Mann, Stephen ^a   Anderson, J L Ross ^a   Perriman, Adam W ^a   Hollander, Anthony P ^a,g  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^e RENISHAW PLC   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGLOBIN; POLYMER; GLYCOLIC ACID DERIVATIVE; GLYCOLIC ACID ETHOXYLATE 4-NONYLPHENYL ETHER; OXYGEN;

BIOENGINEERING; CHEMICAL BINDING; CYTOLOGY; MEMBRANE; POLYMER; PROTEIN;

ARTICLE; ARTIFICIAL MEMBRANE; CELL DEATH; CELL DIFFERENTIATION; CELL ENGINEERING; CELL PROLIFERATION; CELL SURFACE; CELL VIABILITY; CHONDROGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYALINE CARTILAGE; IMMUNOHISTOCHEMISTRY; MEMBRANE BINDING; MESENCHYMAL STEM CELL; NONHUMAN; OXYGEN DIFFUSION; OXYGENATION; PROTEIN BINDING; PROTEIN MODIFICATION; TISSUE ENGINEERING; TISSUE OXYGENATION; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; EVALUATION STUDY; MESENCHYMAL STROMA CELL; PROCEDURES;

ESCHERICHIA COLI; GLYCOLATES; HUMANS; HYALINE CARTILAGE; MESENCHYMAL STROMAL CELLS; MYOGLOBIN; OXYGEN; TISSUE ENGINEERING;

EID: 84937161141     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8405     Document Type: Article

References (26)

1. Berthiaume, F., Maguire, T. J. & Yarmush, M. L. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu. Rev. Chem. Biomol. Eng. 2, 403-430 (2011).
2. Croll, T. I. et al. Modelling oxygen diffusion and cell growth in a porous, vascularising scaffold for soft tissue engineering applications. Chem. Eng. Sci. 60, 4924-4934 (2005).
3. Muschler, G. F., Nakamoto, C. & Griffith, L. G. Engineering principles of clinical cell-based tissue engineering. J. Bone Joint Surg. 86, 1541-1558 (2004).
4. Wernike, E., Li, Z., Alini, M. & Grad, S. Effect of reduced oxygen tension and long-term mechanical stimulation on chondrocyte-polymer constructs. Cell Tissue Res. 331, 473-483 (2008).
5. Volkmer, E. et al. Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng. A 14, 1331-1340 (2008).
6. Kock, L. M., Malda, J., Dhert, W. J. a., Ito, K. & Gawlitta, D. Flow-perfusion interferes with chondrogenic and hypertrophic matrix production by mesenchymal stem cells. J. Biomech. 47, 2122-2129 (2014).
7. Lovett, M., Lee, K., Edwards, A. & Kaplan, D. L. Vascularization strategies for tissue engineering. Tissue Eng. Rev. B 15, 353-370 (2009).
8. Norotte, C., Marga, F. S., Niklason, L. E. & Forgacs, G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30, 5910-5917 (2009).
9. Oh, S. H., Ward, C. L., Atala, A., Yoo, J. J. & Harrison, B. S. Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials 30, 757-762 (2009).
10. Burmester, T., Weich, B., Reinhardt, S. & Hankeln, T. A vertebrate globin expressed in the brain. Nature 407, 520-523 (2000).
11. Herold, S., Fago, A., Weber, R. E., Dewilde, S. & Moens, L. Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress. J. Biol. Chem. 279, 22841-22847 (2004).
12. McNaughton, B. R., Cronican, J. J., Thompson, D. B. & Liu, D. R. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc. Natl Acad. Sci. USA 106, 6111-6116 (2009).
13. Malda, J., Klein, T. J. & Upton, Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng. 13, 2153-2162 (2007).
14. Freed, L. E. et al. Biodegradable polymer scaffolds for tissue engineering. Nat. Biotechnol. 12, 689-693 (1994).
15. Brazhe, N. A. et al. Mapping of redox state of mitochondrial cytochromes in live cardiomyocytes using Raman microspectroscopy. PLoS ONE 7, e41990 (2012).
16. Malda, J. et al. Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling. Biotechnol. Bioeng. 86, 9-18 (2004).
17. Acar, M., Pando, B. F., Arnold, F. H., Elowitz, M. B. & van Oudenaarden, A. A general mechanism for network-dosage compensation in gene circuits. Science 329, 1656-1660 (2010).
18. Yee Koh, M., Spivak-Kroizman, T. R. & Powis, G. HIF-1 regulation: not so easy come, easy go. Trends Biochem. Sci. 33, 526-534 (2008).
19. Déry, M.-A. C., Michaud, M. D. & Richard, D. E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37, 535-540 (2005).
20. Acar, M., Becskei, A. & Van Oudenaarden, A. Enhancement of cellular memory by reducing stochastic transitions. Nature 435, 220-223 (2005).
21. Malda, J., Martens, D. E., Tramper, J., Van Blitterswijk, C. A. & Riesle, J. Cartilage tissue engineering: controversy in the effect of oxygen. Crit. Rev. Biotechnol. 23, 175-194 (2003).
22. Galluzzo, M., Pennacchietti, S., Rosano, S., Comoglio, P. M. & Michieli, P. Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J. Clin. Invest. 119, 865-875 (2009).
23. Fraser, J. et al. Hypoxia-inducible myoglobin expression in nonmuscle tissues. Proc. Natl Acad. Sci. USA 103, 2977-2981 (2006).
24. Xia, L., McDaniel, J. M., Yago, T., Doeden, A. & McEver, R. P. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 104, 3091-3096 (2004).
25. Medof, M. E., Nagarajan, S. & Tykocinski, M. L. Cell-surface engineering with GPI-anchored proteins. FASEB J. 10, 574-586 (1996).
26. Tang, Y. L. et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46, 1339-1350 (2005).